Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Merck
Dow
Harvard Business School
Express Scripts

Last Updated: August 13, 2022

CLINICAL TRIALS PROFILE FOR FIDAXOMICIN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Fidaxomicin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00314951 ↗ Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) Completed Optimer Pharmaceuticals LLC Phase 3 2006-05-02 This is a comparative study to investigate the safety and efficacy of fidaxomicin versus vancomycin in subjects with Clostridium difficile-Associated Diarrhea (CDAD).
NCT00468728 ↗ PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed Optimer Pharmaceuticals LLC Phase 3 2006-10-04 This is a comparative study to investigate the safety and efficacy of PAR-101/OPT-80 (fidaxomicin) versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).
NCT01552668 ↗ Fidaxomicin to Prevent Clostridium Difficile Colonization Withdrawn Centers for Disease Control and Prevention Phase 4 2012-09-01 The purpose of this research study is to evaluate the effectiveness of an antibiotic called fidaxomicin in preventing C. difficile infection.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fidaxomicin

Condition Name

Condition Name for Fidaxomicin
Intervention Trials
Clostridium Difficile Infection 10
Clostridium Difficile 6
Diarrhea 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fidaxomicin
Intervention Trials
Clostridium Infections 30
Infections 19
Communicable Diseases 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fidaxomicin

Trials by Country

Trials by Country for Fidaxomicin
Location Trials
United States 133
Canada 17
United Kingdom 8
Poland 7
France 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Fidaxomicin
Location Trials
California 8
New York 7
Texas 6
North Carolina 6
Massachusetts 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fidaxomicin

Clinical Trial Phase

Clinical Trial Phase for Fidaxomicin
Clinical Trial Phase Trials
Phase 4 13
Phase 3 10
Phase 2 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fidaxomicin
Clinical Trial Phase Trials
Completed 17
Recruiting 7
Terminated 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fidaxomicin

Sponsor Name

Sponsor Name for Fidaxomicin
Sponsor Trials
Optimer Pharmaceuticals LLC 5
Cubist Pharmaceuticals LLC 4
Merck Sharp & Dohme Corp. 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fidaxomicin
Sponsor Trials
Other 35
Industry 26
U.S. Fed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.